Temporal stage and grade migration in surgically treated patients with upper tract urothelial carcinoma

BJU International

Volumn 105, Issue 6, 2010, Pages 799-804

  Lughezzani, Giovanni ^a,c   Jeldres, Claudio ^a   Isbarn, Hendrik ^a,d   Sun, Maxine ^a   Shariat, Shahrokh F ^a   Widmer, Hugues ^b   Arjane, Philippe ^b   Graefen, Markus ^d   Perrotte, Paul ^b   Montorsi, Francesco ^c   Karakiewicz, Pierre I ^a,b  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Cancer specific mortality; Epidemiology; Grade shift; Stage migration; Survival; Upper tract urothelial carcinoma

Indexed keywords

AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER GRADING; CANCER MORTALITY; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE REGISTRY; FEMALE; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEPHROURETERECTOMY; PRIORITY JOURNAL; RACE; TUMOR LOCALIZATION; UPPER TRACT UROTHELIAL CARCINOMA; URINARY TRACT CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEPHRECTOMY; SEER PROGRAM; TREATMENT OUTCOME; UNITED STATES; URETER; URETERAL NEOPLASMS;

EID: 77649261075     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2009.08818.x     Document Type: Article

References (24)

1. Oosterlinck W, Solsona E, van der Meijden AP et al. EAU guidelines on diagnosis and treatment of upper urinary tract transitional cell carcinoma. Eur Urol 2004 46 : 147 154
2. Munoz JJ, Ellison LM. Upper tract urothelial neoplasms: incidence and survival during the last 2 decades. J Urol 2000 164 : 1523 1525
3. Messing E, Catalona W. Urothelial tumor of the urinary tract. In Walsh PC, Retik AD, Vaughan AD, Campbell's Urology, 7th edn. Philadelphia : WB Saunders, 1998 : 2327
4. Zigeuner R, Pummer K. Urothelial carcinoma of the upper urinary tract: surgical approach and prognostic factors. Eur Urol 2008 53 : 720 731
5. Houston Thompson R, Krambeck AE, Lohse CM, Elliott DS, Patterson DE, Blute ML. Elective endoscopic management of transitional cell carcinoma first diagnosed in the upper urinary tract. BJU Int 2008 102 : 1107 1110
6. Bader MJ, Sroka R, Gratzke C et al. Laser therapy for upper urinary tract transitional cell carcinoma: indications and management. Eur Urol 2009 56 : 65 71
7. Anderstrom C, Johansson SL, Pettersson S, Wahlqvist L. Carcinoma of the ureter: a clinicopathologic study of 49 cases. J Urol 1989 142 : 280 283
8. Zungri E, Chechile G, Algaba F, Diaz I, Vila F, Castro C. Treatment of transitional cell carcinoma of the ureter: is the controversy justified? Eur Urol 1990 17 : 276 280
9. Babaian RJ, Johnson DE. Primary carcinoma of the ureter. J Urol 1980 123 : 357 359
10. Mellemgaard A, Carstensen B, Norgaard N, Knudsen JB, Olsen JH. Trends in the incidence of cancer of the kidney, pelvis, ureter and bladder in Denmark 1943-88. Scand J Urol Nephrol 1993 27 : 327 332
11. McLaughlin JK, Silverman DT, Hsing AW et al. Cigarette smoking and cancers of the renal pelvis and ureter. Cancer Res 1992 52 : 254 257
12. Laing C, Hamour S, Sheaff M, Miller R, Woolfson R. Chinese herbal uropathy and nephropathy. Lancet 2006 368 : 338
13. Debelle FD, Vanherweghem JL, Nortier JL. Aristolochic acid nephropathy: a worldwide problem. Kidney Int 2008 74 : 158 169
14. Jensen OM, Knudsen JB, McLaughlin JK, Sorensen BL. The Copenhagen case-control study of renal pelvis and ureter cancer: role of smoking and occupational exposures. Int J Cancer 1988 41 : 557 561
15. Ries LA, Krapcho M et al. SEER Cancer Statistics Review, 1975-2004. Bethesda, MD: National Cancer Institute. Available at: http://seer.cancer.gov/ csr/1975-2004/ based on November 2006 SEER data submission, posted to SEER website, last accessed January 2007
16. Melamed MR, Reuter VE. Pathology and staging of urothelial tumors of the kidney and ureter. Urol Clin North Am 1993 20 : 333 347
17. Kwak C, Lee S, Jeong I, Ku J. Adjuvant systemic chemotherapy in the treatment of patients with invasive transitional cell carcinoma of the upper urinary tract. Urology 2006 68 : 53 7
18. Bamias A, Deliveliotis C, Fountzilas G et al. Adjuvant chemotherapy with paclitaxel and carboplatin in patients with advanced carcinoma of the upper urinary tract: a study by the Hellenic Cooperative Oncology Group. J Clin Oncol 2004 22 : 2150 2154 (Pubitemid 41095148)
19. Maulard-Durdux C, Dufour B, Hennequin C et al. Postoperative radiation therapy in 26 patients with invasive transitional cell carcinoma of the upper urinary tract: no impact on survival? J Urol 1996 155 : 115 117 (Pubitemid 126426443)
20. Czito B, Zietman A, Kaufman D, Skowronski U, Shipley W. Adjuvant radiotherapy with and without concurrent chemotherapy for locally advanced transitional cell carcinoma of the renal pelvis and ureter. J Urol 2004 172 : 1271 1275
21. Gupta R, Paner GP, Amin MB. Neoplasms of the upper urinary tract: a review with focus on urothelial carcinoma of the pelvicalyceal system and aspects related to its diagnosis and reporting. Adv Anat Pathol 2008 15 : 127 139
22. Kang CH, Yu TJ, Hsieh HH et al. The development of bladder tumors and contralateral upper urinary tract tumors after primary transitional cell carcinoma of the upper urinary tract. Cancer 2003 98 : 1620 1626
23. Mullerad M, Russo P, Golijanin D et al. Bladder cancer as a prognostic factor for upper tract transitional cell carcinoma. J Urol 2004 172 : 2177 2181
24. Sanderson KM, Cai J, Miranda G, Skinner DG, Stein JP. Upper tract urothelial recurrence following radical cystectomy for transitional cell carcinoma of the bladder: an analysis of 1,069 patients with 10-year followup. J Urol 2007 177 : 2088 2094